Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-08-07 00:00:00 ET · period of report 2025-08-05 · accession 0001765581-25-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-07 | 2025-08-05 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | F - Tax | $116.10 | -577 | 40.8K | -1% | -$67.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-08-05 | F | D | 577 | $116.10 | 40,815 | D | — | — | (F2) The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025. |